Results 131 to 140 of about 7,953 (182)
Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. [PDF]
Chen W +8 more
europepmc +1 more source
Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. [PDF]
Lee AYS.
europepmc +1 more source
Evidence for M2 Muscarinic Receptor Antagonist Delay of Myopia Development Through Activation of Kir3.4 Channel in the Retina of Guinea Pigs. [PDF]
Zhou H +8 more
europepmc +1 more source
Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride. [PDF]
Pejčić AV.
europepmc +1 more source
Chinese expert consensus on intranasal anticholinergics for allergic rhinitis. [PDF]
Li X +26 more
europepmc +1 more source
Cholinergic system in schizophrenia: A systematic review and meta-analysis. [PDF]
Saint-Georges Z +7 more
europepmc +1 more source
Cholinergic heterogeneity facilitates synchronization and information flow in a whole-brain model
Dalla Porta L +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A model of the human M2 muscarinic acetylcholine receptor
Journal of Computer-Aided Molecular Design, 2002The M2 muscarinic acetylcholine receptor belongs to the family of rhodopsin like G-Protein Coupled Receptors. This subtype of muscarinic receptors is of special interest because it bears, aside from an orthosteric binding site, also an allosteric binding site.
Kirstin, Jöhren, Hans-Dieter, Höltje
openaire +2 more sources

